Trial
NCT05264974
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
Florida Department of Health
Condition
Melanoma
Intervention
Autologous total tumor mRNA loaded DOTAP liposome vaccine
Why stopped
GMP facility production hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-27